Oncology Nutrition Market Report 2025

This Oncology Nutrition report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The oncology nutrition market size has grown rapidly in recent years. It will grow from $1.9 billion in 2024 to $2.1 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to aging population, improved healthcare infrastructure, research and development investments, patient-centric care, rise in healthcare spending.

The oncology nutrition market size is expected to see strong growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing cancer incidence, rise in demand for nutritional food, increase in clinical trials globally, rising disposable income. Major trends in the forecast period include personalized nutrition, immuno-nutrition, genomic nutrition, integrative medicine, value-based care.

The increasing prevalence of cancer is a significant factor contributing to the anticipated growth of the oncology nutrition market. Cancer incidence, which refers to the number of new cancer cases within a specific population over a defined period, has been on the rise. Individuals undergoing cancer treatment require nutrition that meets their specific dietary needs, driving the demand for oncology nutrition products. For example, the American Cancer Society reported in January 2023 that the number of cancer cases had increased to 1,958,310 in 2023, marking a growth of 3.16% from 1,898,160 in 2021. Consequently, the escalating incidence of cancer is expected to be a driving force for the expansion of the oncology nutrition market.

The growth of the oncology nutrition market is also anticipated to be fueled by increasing investments in cancer research. Investment in cancer research involves allocating financial resources to support scientific endeavors aimed at understanding, preventing, diagnosing, and treating cancer. Heightened research funding facilitates a deeper comprehension of the intricate relationship between nutrition and cancer, leading to the development of specialized oncology nutrition products tailored to the unique dietary requirements of cancer patients. For instance, in March 2022, the Department of Health and Aged Care, a government agency based in Australia, allocated $893.5 million to enhance cancer services and outcomes. This increased investment in cancer research is expected to drive the growth of the oncology nutrition market.

Major companies in the oncology nutrition market are dedicated to developing innovative solutions, such as nutrition specifically tailored for cancer patients, to enhance treatment outcomes, support immune function, manage side effects related to treatment, and improve overall quality of life during and after cancer therapy. Nutrition for cancer patients encompasses specialized dietary plans and nutritional interventions aimed at addressing the unique needs of individuals undergoing cancer treatment. For example, in June 2024, AEACAP, a patient support association based in Spain, introduced a new nutrition series aimed at assisting cancer patients and their caregivers. This initiative includes a collection of videos released every two weeks, presented by a qualified nutritionist. The series seeks to offer vital information on diet and nutrition throughout and after cancer treatment, emphasizing the essential role that proper nutrition plays in improving treatment outcomes and enhancing the quality of life for those affected by cancer.

Major companies in the oncology nutrition market are focusing on the development of personalized nutrition products to gain a competitive edge. Tality, a medical food based on personalized nutrition designed to inhibit the growth of cancer cells within a short timeframe, is one such example. Filtricine Inc., a US-based biotechnology company, introduced Tality in September 2023, utilizing personalized nutrition to target nutrients essential for cancer cells while sparing normal cells. The Tality meal plan, known as the TND diet, can be used alongside standard patient care or as a standalone treatment, with potential benefits observable in as little as four weeks, according to early results.

In January 2024, Danone S.A., a food company based in France, formed a partnership with National Resilience, Inc. This collaboration aims to improve nutritional care for cancer patients by incorporating a specialized nutrition support module into Resilience's digital oncology platform, focusing on addressing cancer-related malnutrition and enhancing patient outcomes and quality of life during treatment. National Resilience, Inc., a manufacturing and technology company located in the U.S., is committed to expanding access to complex medicines.

Major companies operating in the oncology nutrition market include B. Braun Melsungen AG, Danone India, Abbott Laboratories, Nestle S.A., Hormel Foods Corporation, Meiji Holdings Co. Ltd., Pfizer Inc., Baxter International Inc., Mead Johnson Nutrition Company LLC, Fresenius Kabi AG, Mead Johnson & Company LLC, Global Health Products Inc., Nutricia, Cambrooke Therapeutics Inc., Kate Farms Inc., Real Food Blends LLC, Abbott Nutrition, Fresenius Kabi USA LLC, Medtrition Inc., Nutra Balance Products, Nutritional Medicinals LLC, Pinnacle Foods Inc., Primus Pharmaceuticals Inc., Solace Nutrition, The Simply Good Foods Company, Unimed Pharma LLC, Vitaflo USA LLC.

North America was the largest region in the oncology nutrition market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the oncology nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Oncology nutrition involves the implementation of a healthy and balanced diet specifically tailored for cancer patients. Consuming the right types of food before, during, and after treatment is crucial for helping patients feel better and maintain strength. The goal of oncology nutrition is to enhance clinical outcomes in specific cancer types.

The primary categories of cancer addressed in oncology nutrition include blood cancer, breast cancer, stomach and gastrointestinal cancers, liver cancer, pancreatic cancer, and others. Stomach and gastrointestinal cancers encompass malignancies occurring in any part of the stomach. Various nutritional approaches, such as enteral nutrition and parenteral nutrition, are employed across different settings, including hospitals, homecare, specialty clinics, and other end users.

The oncology nutrition market research report is one of a series of new reports that provides oncology nutrition market statistics, including oncology nutrition industry global market size, regional shares, competitors with an oncology nutrition market share, detailed oncology nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the oncology nutrition industry. This oncology nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

The oncology nutrition market includes revenues earned by entities by bladder cancer, breast cancer, colorectal cancer, kidney cancer, and lung cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.